Adult female Wistar rats (in 12 hr light/12 hr dark) were pinealectomized (PX) or sham-operated (SO) either 21 days after ovariectomy or on the 15-17th day of pregnancy.
(PX) or sham-operated (SO) either 21 days after ovariectomy or on the 15-17th day of pregnancy.
Ovariectomized (OVX) rats were injected with estrogen and progesterone (EP) 48 hr before decapitation. Melatonin, serotonin or arginine vasotocin (AVT; 50, 100 or 200µg) were administered intravenously into OVX-EP rats 9 days after pineal removal.
In PX and SO groups, the same study was done 3 days after delivery.
Sera and pituitaries were collected 30 min after injection in order to determine prolactin (PRL) levels. Fifty µg melatonin significantly suppressed serum PRL levels in PX-OVX-EP rats and PX postpartum rats, but had not significant effect in SO-OVX-EP or PX postpartum rats. After administration of AVT, serum PRL levels markedly rose in PX and SO rats. These results suggest that melatonin may act not only to stimulate but also to inhibit rat PRL secretion and that the stimulatory function would be superior to its inhibitory function when the pineal gland is intact, prolactin; pineal gland; melatonin; serotonin; arginine vasotocin
In mammals pituitary prolactin (PRL) secretion is regulated by stimulatory and inhibitory mechanisms. The pineal gland is usually considered to stimulate PRL secretion, because decrements of circulating PRL have been observed in pinealectomized (PX) rats (Donofrio and Reiter 1972; Relkin 1972 ; Ronnekleive and MacCann 1975) , and because administration of pineal extract (Moskowska 1967) or pineal substances (Kamberi et al. 1971 ; Kuew-Husing and Meites 1973; Pavel et al. 1975 ) stimulates PRL secretion. We have previously reported that pinealectomy lowered serum PRL levels in ovariectomized (OVX) female rats treated with estrogen and progesterone (Takahashi et al. 1978 ). On the contrary, an increase in serum PRL has been observed in PX pregnant and PX postpartum rats (Takahashi et al. 1979 ). These contradictory results suggest that the pineal gland acts not only to stimulate but also to inhibit pituitary PRL secretion.
In the present study, for the purpose of clarifying the mechanisms of pineal action on PRL secretion, we investigated the influences of administration of pineal bioactive substances (melatonin, serotonin and arginine vasotocin) on serum and pituitary PRL levels in OVX rats treated with estrogen and progesterone and postpartum rats after pinealectomy or sham operation.
MATERIALS AND METHODS
Animals. Female Wistar rats (10 weeks old, 200±20 g) were used in all experiments. They were kept in cages with a 12 hr light/12 hr dark photoperiod, maintained at a temperature of 22±2°C, and provided with food and water ad libitum.
Ovariectomized rats. Rats were ovariectomized (OVX) in order to eliminate any influence of sex cycle on PRL secretion. Subsequently, they were pinealectomized (PX) according to the modified method of Kuszack and Robin (1977) or were subjected to a sham-operation (SO) 21 days after ovariectomy. Seven days after the operation, they were injected intramuscularly with 50,tg estrogen and 2 mg progesterone (OVX-EP) and were decapitated 48 hr after the steroid treatment.
Postpartum rats. Rats were subjected to pinealectomy or sham operation on the 15-17th day of pregnancy. They were delivered of their litters in separate cages, allowed to suckle until the 3rd day of postpartum, and then decapitated 30 min after separation from their litters in order to avoid the influence of suckling.
The pineal substances. Preparation of the pineal substances was as follows : 1) Melatonin (Sigma Chem. Co.) was dissolved in 95% ethylalcohol and diluted with physiological saline to make melatonin solutions of 100, 200 and 400, tg/ml containing 0.3% ethylalcohol. ii) Serotonin (Sigma Chem. Co.) was dissolved in physiological saline resulting in the same concentrations as those of the melatonin. iii) Arginine vasotocin (AVT) (Bachem. Inc.) was dissolved in Ringer's solution containing 0.31% (w/v) lactose resulting in the same concentrations as above. Each of them was injected into the femoral veins of OVX-EP rats and postpartum lactating rats at doses of 50, 100 or 200 µg in 0.5 ml under light ether anesthesia. As a control, physiological saline containing 0.3% ethylalcohol was injected. Rats were decapitated 30 min after injection according to the preliminary experiment (unpublished).
Preparation for radioimmunoassay. Blood samples and pituitaries were collected between 15:00-17:00. Blood samples were centrifuged at 3,000 rpm for 15 min and sera were obtained. A pituitary gland was homogenized in 4.0 ml physiological saline and centrifuged at 2,000 rpm for 5 min to obtain supernatant. The sera and pituitary homogenates were stored at -20°C. PRL contents were determined by double antibody radioimmunoassay and expressed in terms of NIAMDD rat PRL-PR-1 (11.0 iu/mg). Significance was calculated according to the Student's t-test. Levels were given by mean±s.E.
RESULTS
Melatonin 0 V X -EP rats. Control levels of serum PRL in PX rats (167.8±16.1 ng/ml) (mean ± S. E .) were significantly (p<0.001) lower than those in SO rats (350.9± 33.9 ng/ml). Administration of 50µg melatonin decreased serum PRL levels of PX rats (82.1±9.4 ng/ml) to half the control levels (p<0.005). But 100 ,ccg melatonin somewhat increased PRL levels, and 200 µg melatonin significantly (p<0.001) raised serum PRL levels of PX rats (365.6+41.3 ng/ml). In SO rats, 50 µg melatonin did not cause a decrement of serm PRL levels, but an augmentation of PRL levels was observed after injection of 100 and 200µg melatonin. Especially, administration of 200µg melatonin significantly (p <0.005) increased serm PRL levels (587.3+40.6 ng/ml) as compared to the control levels (Fig. 1a) .
As to pituitary PRL levels, 50 µg melatonin did not significantly suppress the levels in PX and SO rats. An increase of pituitary PRL levels was found after injection of 100 or 200 µg melatonin, but the increase was not statistically significant in either dose (Fig. 2a) .
Postpartum rats. Control levels of serum PRL in PX rats (87.3±17.3 ng/ml) were significantly (p<0.001) higher than those in SO rats (44.0±7.3 ng/ml). Fifty µg melatonin significantly (p<0.02) lowered serum PRL levels in PX rats (31.5±2.9 ng/ml), the decrease being greater than that in the control group. On the contrary, 100µg melatonin caused a 4.6-fold (p<0.001) increase in PX rats (397.4± 44.9 ng/ml). In SO rats, serum PRL levels considerably rose after administration of 50 µg melatonin (95.1+18.4 ng/ml) (p<0.05), 100µg melatonin (554.0+64.9 ng/ml) (p<0.001), and 200µg melatonin (517.3± 88.3 ng/ml) (p<0.001), as compared with the control group (Fig. 1b) .
In contrast to the OVX-EP rats, PX postpartum rats showed a 2.4-fold (p <0.01) increase in pituitary PRL levels after the 50µg melatonin (2232.9+497.6 ng/mg AP) (AP: anterior pituitary). A 2.6-fold increase was observed in the SO group (3035.9± 356.8 ng/mg AP) (p<0.001). However, decrements were observed in pituitary PRL levels in both groups after injection of 100 and 200 µg melatonin, although each level was higher than that of the control (Fig. 2b) . The number of samples was 6. Mean±s.E. Significance was calculated by comparing with control. *p<0001, p<0.002, p<0.005. a : Melatonin was administered to ovariectomized rats primed with 50 µg estrogen and 2 mg progesterone (OVX-EP) 48 hr before decapitation. b : Melatonin was administered to postpartum lactating rats 3 days after delivery. Serotonin OVX-EP rats. After administration of 50µg serotonin, serum PRL levels did not significantly vary in either PX or SO rats. Two hundred µg serotonin markedly (p<0.005) enhanced serum PRL levels in PX rats (29.43+28.4 ng/ml), but not in SO rats, although some increment was found (Fig. 3a) .
Pituitary PRL levels were insignificantly suppressed by 50 µg serotonin in either PX or SO rats. In PX rats, 200 µg serotonin considerably (p < 0.001) decreased pituitary PRL levels (714.0+21.7 ng/mg AP). In SO rats, a significant (p<0.05) decline was caused by 100 µg serotonin (710.1+83.5 ng/mg AP) (Fig. 4a) .
Postpartum rats. There was no statistically significant difference in serum PRL level in PX rats after injection of 50, 100 or 200 µg serotonin, although a tendency towards an increase was found in each case. On the contrary, serum PRL levels in SO rats were augmented by 50 µg serotonin (94.9+10.2 ng/ml) (p < 0.005), by 100µg serotonin (132.0±20.0 ng/ml) (p<0.005), and by 200 µg serotonin (90.9±5.9 ng/ml) (p<0.005) as compared with the control levels (44.0±7.3 ng/m1) (Fig. 3b) .
No significant differences were observed in pituitary PRL level in PX rats in any doses of serotonin. Pituitary PRL levels in SO rats significantly fell after injection of 100µg serotonin (617.4±34.1 n g/mg AP) (p<0.001), and 200 µg serotonin (879.9±77.7 ng/mg AP) (p<0.01) in comparison with levels in the control group (1165.5±49.7 ng/mg AP) (Fig. 4b) .
AVT OV X -EP rats. As to PX rats, 50 µg AVT caused a 2.4-fold (p<0.001) increment of serum PRL levels (406.0±28.3 ng/ml) as compared with the control group (167.8±16.1 ng/m1). Similarly, 100 µg AVT caused a 2.6-fold (p<0.001) increase The number of samples was 6. Mean+s.E. Significance was calculated by comparing with control.
*,p<0.001, ~p<0.01, +p<0.02. a : Melatonin was administered to ovariectomized rats primed with 50 ,ccg estrogen and 2 mg progesterone (OVX-EP) 48 hr before decapitation. b : Melatonin was administered to postpartum lactating rats 3 days after delivery.
(437.0±50.9 ng/ml), and 200 µg AVT resulted in a 2.8-fold (p<0.001) increase (462.0±22.5 ng/ml). Serum PRL levels in SO rats were higher than those in the control group (350.9+33.9 ng/ml) when AVT was injected at doses of 50 µg (437.0 ±42.4 ng/ml), 100 µg (484.5±15.7 ng/ml) (p<0.02), and 200µg (569.0±51.9 ng/ml) (p<0.005) (Fig. 5a ). Serum PRL levels in PX and SO rats were not significantly different.
In PX rats, 100µg AVT significantly (p<0.o01) raised pituitary PRL levels (1445.4+19.0 ng/mg AP), as did 200 µg AVT (1297.7+49.3 ng/mg AP) (p<0.001) as compared with the levels in the control group (1079.0±39.8 ng/ml AP). However, pituitary PRL levels in SO rats showed no significant variation after treatment with AVT (Fig. 6a) . Experimental conditions were the same as described in "melatonin".
Mean+s.E. *p<0.005. a : Serotonin was administered to ovariectomized rats primed with estrogen and progesterone (OVX-EP). b : Serotonin was administered to postpartum lactating rats. Postpartum rats. A significant increase was observed in serum PRL levels in PX rats after administration of AVT. As compared with levels in the control group (87.3±17.3 ng/ml), 50 pg AVT caused a 2.1-fold (p<0.05) increase (185.4± 33.3 ng/ml), 100 µg AVT, a 3.8-fold (p<o.001) increase (335.0±41.5 ng/ml), and 200 µg AVT, a 5.0-fold (p<0.001) increase (438.0±21.8 ng/ml). As to SO rats, a 5.0-fold (p<0.001) increase in serum PRL levels was found after injection of 50 µg AVT (220.0±12.9 ng/ml) in comparison to levels in the control group (44.0±7.3 ng/ml). Moreover, a 100 µg injection of AVT resulted in a 6.3-fold (p<0.o01) increase (279 .0 ±37.4 ng/ml), and a 200 pg injection of AVT resulted in a 12.5-fold (p<0.001) increase (507.7±62.8 ng/ml) (Fig. 5b) . There was no statistically significant difference in serum PRL level between PX and SO groups . rats. Experimental conditions were the same as described in "melatonin".
Mean+s.E. *p<0.001, ~p<0.005, p< 0.02, § p<0.05. a : AVT was administered to ovariectomized rats primed with estrogen and progesterone (OVX-EP). b : AVT was administered to postpartum lactating rats. rats. Experimental conditions were the same as described in "melatonin".
Mean+s.x. *p<0.001, tp<0.005. a: AVT was administered to ovariectomized rats primed with estrogen and progesterone (OVX-EP). b : AVT was administered to postpartum lactating rats.
One hundred µg AVT only significantly lowered (p<0.005) pituitary PRL levels (793.5±16.2 ng/m.g AP) as compared with the control levels (1165.5+49.7 ng/mg AP). Except for this, no significant difference was observed in pituitary PRL levels either in PX rats or in SO rats after injection of AVT (Fig. 6b) .
DISCUSSION
The pineal functions are mainly attributed to several bioactive substances, i.e. indolamines such as melatonin and serotonin, and peptides such as AVT, etc. The pineal gland acts on the pituitary to release PRL (Blask and Reiter 1975; Pavel 1978) and to inhibit the release of gonadotropin (Wurtman et al. 1963; Kamberi 1973) . Hence, the PRL releasing action of the pineal gland would be ascribed to these substances. However, since the antigonadotropic action of melatonin was not observed except when there was an intact pineal gland and when melatonin was injected in the afternoon (Tamarkin et al. 1976 ), we hypothesized that melatonin would not play a stimulatory role on PRL secretion under certain experimental conditions. In the present study, 50µg melatonin lowered serum PRL levels of PX rats in both OVX-EP and postpartum groups. On the contrary, in rats maintained with intact pineal glands, the same dose of melatonin markedly raised serum PRL levels in early postpartum period. Melatonin induced an increase in serum PRL levels also in OVX-EP rats.
We have previously observed that pinealectomy increased serum PRL levels in postpartum rats (Takahashi et al. 1979) , and that 50 µg melatonin depressed the high serum PRL levels of pinealectomized rats, but increased the pituitary PRL levels. This result may be considered as "melatonin reversal", because the stimulatory effect of exogenous melatonin on PRL secretion is reversed in the absence of the pineal gland. When a large dose of melatonin was administered (>100 µg), it resulted in an increase of serum PRL levels even in PX groups. As to serotonin and AVT, these substances did not suppress PRL secretion, but an increment was usually observed after AVT treatment whether or not there was an intact pineal gland. These results suggested an inhibition of PRL secretion by melatonin.
In doing research into a physiological effect of bioactive substance, it is important to consider whether the effect brought about by the various doses of the substance was physiological or pharmacological. Melatonin contents in the pineal gland change with a circadian rhythm and, in rats, vary from 0.5 to 7 ng Jgland (Quay 1963) . The percent of intravenously injected melatonin which reaches the pineal gland is reported to be 0.02% (Axelrod and Wurtman 1966) . According to this ratio, 10 ng of a 50 µg melatonin injection is considered to reach the pineal gland, and thus it may be regarded as within the physiological range. When the administered melatonin was over 100µg, an increment of serum PRL levels was observed even in the PX rats. This may be explained as follows: a large dose of melatonin raises the level of hypothalamic serotonin contents, because melatonin inhibits MAO (monoamine oxidase) to metabolize serotonin (Urry and Ellis 1975) and as a result, increased serotonin counteracts dopaminergic inhibition to stimulate the release of PRL.
The above described effects of melatonin may be considered to be pharmacological rather than physiological.
Since 50 µg melatonin decreased serum PRL levels in PX rats, it is suggested that the physiological dose of melatonin does not stimulate PRL secretion but inhibits it. On the contrary, the same dose of melatonin enhanced serum PRL levels in rats in the presence of the intact pineal gland. This increment is thought to be caused by another more effective substance, possibly AVT, which may be released by melatonin in the pineal gland. The reasons are as follows : 1) The amount of AVT in cerebrospinal fluid rises after administration of melatonin (Pavel et al. 1975 ). 2) Serotonin contents in the hypothalamus decline with disappearance of AVT after pineal removal and are restored by administration of AVT (Pavel et al. 1980 ). 3) PRL secretion is promoted by serotonin injected into the third ventricle, but the stimulatory effect of serotonin is diminished by the pretreatment of melatonin (Iwasaki et al. 1978 ). 4) The uptake of serotonin to the hypothalamus in vitro is decreased by addition of melatonin (Cardinali et al. 1975) . From these reported observations and our present results it may be hypothesized that the pineal gland has alternate systems to stimulate and to inhibit pituitary PRL secretion. Stimulation is considered to be related to the augmentation of hypothalamic serotonin contents affected by AVT which is possibly released by melatonin. On the other hand, inhibition is considered to be an effect of melatonin itself ; it inhibits serotonin uptake into hypothalamic neurons. These two systems of inhibition and stimulation may alter the dominance according to physiological conditions, for instance, to steroid hormone level. iVIelatonin treatment probably activates the stimulatory system via AVT, and this stimulation is more potent than its inhibitory effect when the pineal gland is intact.
It is well known that the pineal gland suppresses PRL secretion in blindanosmic rats (Ronnekleive and MacCann 1975; Leadem and Blask 1982a, b) . Although blind-anosmic rats show ovarian hypotrophy induced by the pineal gland, this suppression of PRL is reported to be independent of decrease in sex-steroid levels caused by ovarian regression (Leadem and Blask 1982b) . Also in rats, administration of melatonin does not affect (Cardinali et al. 1979) or decreases (Blask and Nodelman 1979) serum PRL levels. Therefore, we again suggest that the pineal gland of rats acts also to inhibit PRL secretion probably by effect of melatonin as above described. Recently, however, Vaughan et al. (1982) reported that partially purified bovine pineal peptide fraction decreased rat serum PRL levels. There may exist a certain substance(s) except for melatonin in the pineal gland which can inhibit PRL secretion.
We have described the possible mechanisms of the pineal actions on pituitary PRL secretion based on our results and other reported observations. however, several biorhythms are reported to be present in the functions of neuroendocrine systems in the pineal and hypothalamus, so the actions of the pineal gland on pituitary PRL secretion are thought to vary with circadian, sex-cyclic and seasonal 
